viernes, 11 de septiembre de 2020

Resuming Normal Drug and Biologics Manufacturing Operations During the COVID-19 Public Health Emergency | FDA

Resuming Normal Drug and Biologics Manufacturing Operations During the COVID-19 Public Health Emergency | FDA

US Food and Drug Administration

Recently Posted Guidance Documents

No hay comentarios: